Date: 01/02/2024

Jason S. Park, PharmD

Amir Hossein Saeidian, PhD

Leila Youssefian, PhD

Katherine E. Kondratuk, MD

Howard B. Pride, MD

Hassan Vahidnezhad, PhD

Jouni Uitto, MD, PhD

Published: August 09, 2022DOI:https://doi.org/10.1016/j.jaad.2022.08.012

Great advances have been made in the field of heritable skin disorders using next-generation sequencing (NGS) technologies (ie, whole-genome sequencing, whole-exome sequencing, whole-transcriptome sequencing, and disease-targeted multigene panels). When NGS first became available, the cost and lack of access to these technologies were limiting factors; however, with decreasing sequencing costs and the expanding knowledge base of genetic skin diseases, fundamental awareness of NGS has become prudent.

Read full article here: https://www.jaad.org/article/S0190-9622(22)02444-6/fulltext